.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Citi
UBS
Cipla
QuintilesIMS
McKesson
Colorcon
Fuji
McKinsey
Healthtrust

Generated: July 25, 2017

DrugPatentWatch Database Preview

ARISTOCORT Drug Profile

« Back to Dashboard

What is the patent landscape for Aristocort, and when can generic versions of Aristocort launch?

Aristocort is a drug marketed by Sandoz Inc and Astellas and is included in fourteen NDAs.

The generic ingredient in ARISTOCORT is triamcinolone. There are fifty-one drug master file entries for this compound. Additional details are available on the triamcinolone profile page.

Summary for Tradename: ARISTOCORT

Patents:0
Applicants:2
NDAs:14
Bulk Api Vendors: see list40
Clinical Trials: see list1
Patent Applications: see list5,623
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARISTOCORT at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz Inc
ARISTOCORT
triamcinolone diacetate
INJECTABLE;INJECTION012802-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT A
triamcinolone acetonide
CREAM;TOPICAL088819-001Oct 16, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT
triamcinolone diacetate
SYRUP;ORAL011960-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT
triamcinolone acetonide
CREAM;TOPICAL083017-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Astellas
ARISTOCORT
triamcinolone
TABLET;ORAL011161-010Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Merck
Federal Trade Commission
Fuji
Daiichi Sankyo
Queensland Health
Teva
Baxter
McKinsey
Argus Health
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot